A U.S. Food and Drug Administration (FDA) advisory committee recently determined that phenylephrine, an ingredient commonly used to treat sinus and nasal congestion, is ineffective in treating these symptoms. This was apparent from research for years, yet large...
News
Latest News
Rubio Habla en La Poderosa
El senador estadounidense Marco Rubio (R-FL) habló con César Grajales de La Poderosa 670 AM en El Panorama Político, sobre la crisis fronteriza, sobre cómo los hispanoamericanos se ven afectados con la realidad del país, sobre los cargos contra el senador Bob Menéndez...
Rubio, Colleagues Reintroduce Bill to Protect Rights of Pregnant Students
Pregnant students are sometimes discriminated against by their schools, either intentionally or unintentionally and there is a concerning lack of awareness about the resources and rights available to them. Due to a lack of services and discrimination, these women may...
Rubio, Colleagues Reintroduce Intelligence Community Workforce Agility Protection Act
Currently, intelligence community civilians are subject to certain tax penalties for job-related relocation requirements, but active-duty military servicemembers are not subjected to the same penalties. These tax benefits, including the ability to deduct moving...
Rubio Delivers Remarks at Senate Intelligence Hearing
Vice Chairman of the Senate Select Committee on Intelligence Marco Rubio (R-FL) delivered opening remarks and questioned witnesses at a hearing on countering China’s influence in the United States. Watch Rubio’s opening remarks here as well as Part I and Part II of...
Rubio-led Resolution to Raise Awareness for Spinal Cord Injuries Passes Senate
Approximately 302,000 Americans live with spinal cord injuries. To help these people achieve a better quality of life, there is a need to increase education and invest in research. U.S. Senators Marco Rubio (R-FL) and Tammy Baldwin (D-WI) successfully led a bipartisan...
Rubio To CDC: Clear Zika Virus Testing Backlog, Prioritize Tests For Pregnant Women
Washington, D.C. – Following reports of a Zika virus testing backlog, U.S. Senator Marco Rubio (R-FL) today urged the Centers for Disease Control and Prevention (CDC) to use whatever steps necessary to dedicate currently available resources to clearing its current backlog, and to prioritize completing tests for women who are pregnant.
Rubio announced his support for the $1.9 billion request to combat the Zika virus during a press conference last Friday following a briefing with state, local and Puerto Rican officials and health experts. He stressed the importance that taxpayer money only be spent on programs to combat the Zika virus.
In a letter sent today to CDC Director Dr. Tom Frieden, Rubio outlined several obstacles the country faces in fighting Zika, including the length of time it takes for diagnostic tests to be completed. Until Congress approves emergency funding to fight the Zika virus, Rubio encouraged the CDC to clear its current Zika virus testing backlog, using existing resources, and to prioritize testing for women who are pregnant.
“These essential steps will help us to not only ease mothers’ minds who test negative for the virus, but also to provide critical care for a child whose mother tests positive for the Zika virus,” Rubio wrote in the letter. “We know that screening for microcephaly should happen early and often, and receiving the results of a diagnostic test is the first step in that process. The CDC should have the capability to provide those services immediately to those who are waiting.”
“While it is my ultimate hope that the U.S. Food and Drug Administration (FDA) will approve a commercial Zika diagnostic test in the near future so that these tests are more broadly available, the CDC must take action now to reduce the backlog and to prioritize pregnant women for diagnostic testing,” Rubio continued.
A PDF of the letter is available here and the full text is below:
Dr. Tom Frieden
Director
The Centers for Disease Control and Prevention
1600 Clifton Road
Atlanta, Georgia 30333
Dear Dr. Frieden,
I write to you today to express my concern with the Centers for Disease Control and Prevention’s (CDC) current backlog of diagnostic tests for the Zika virus.
On April 8, I hosted a briefing in Miami, Florida with representatives from state health departments, local health departments and county government officials, infectious disease experts, and health officers from Puerto Rico to learn more about the Zika virus. While I heard many obstacles that we face in fighting Zika, one aspect I heard about repeatedly was the distressing length of time it takes for diagnostic tests to be completed. I have subsequently seen media reports of pregnant women who have waited up to a month for the CDC to complete their diagnostic tests for the Zika virus, while fearful mothers anxiously wait to know their child’s fate.
This wait time is unacceptable. As you may know, immediately following the briefing I received, I publicly offered my support for the President’s emergency supplemental funding request to combat Zika and urged that the money only be spent directly on this issue. But until Congress approves the request, I urge the CDC to use whatever steps necessary to dedicate currently available resources to clearing its current backlog of Zika diagnostic tests, and to prioritize these tests for women who are pregnant.
These essential steps will help us to not only ease mothers’ minds who test negative for the virus, but also to provide critical care for a child whose mother tests positive for the Zika virus. We know that screening for microcephaly should happen early and often, and receiving the results of a diagnostic test is the first step in that process. The CDC should have the capability to provide those services immediately to those who are waiting.
While it is my ultimate hope that the U.S. Food and Drug Administration (FDA) will approve a commercial Zika diagnostic test in the near future so that these tests are more broadly available, the CDC must take action now to reduce the backlog and to prioritize pregnant women for diagnostic testing. Thank you in advance for your consideration.
Sincerely,
Marco Rubio
United States Senator